Go to Page # Page of 25
loading

Reaching Value Inflection Points in Neurodegenerative Diseases

 Bionure Farma
  25th-Jun-2019
Description: Bionure ambition is to propose new disease-modifier treatments able to slow down, stop or reverse the evolution into disability in patients suffering from neuronal damage.
Views: 783
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Bionure Farma
 ‐ More of their Presentations
Contents:
Reaching Value Inflection Points in Neurodegenerative Diseases
BioEquity 2019

Bionure in 4 questions
Q1: Bionure’s focus: Central nervous system and neurodegenerative diseases

Q2: BN201, the lead drug-candidate
Q3: A seasoned team to execute strategy and plans
Q4: Next steps for Bionure & BN201

2

Q1: Bionure’s focus: CNS and neurodegenerative diseases

• Range of conditions ... See more

Recent Presentations

Tine Peeters
21 July, 2019

FDA's Approach to the Opioids Crisis

FDA is working in a prioritized way in multiple areas to confront opioid overdoses while working to ensure patients receive appropriate pain treatment.

...
20 July, 2019
...
19 July, 2019